Annette Lennerling|Annika Kisch|Anna Forsberg
Non-adherence to Immunosuppressant after Lung Transplantation – A Common Risk Behavior
University of Gothenburg|Sahlgrenska University Hospital|Skåne University Hospital|Lund University|Lund University|Skåne University Hospital
background lung transplantation lifelong treatment immunosuppressive medication required prevent rejection graft loss adherence immunosuppressive treatment may difficult lung recipient adherence essential nonadherence immunosuppressive treatment lead graft loss death objective aim crosssectional study investigate prevalence nonadherence 1 5 years lung transplantation relation symptom burden health literacy psychological wellbeing relevant demographic variables methods 117 adult lung recipients due annual followup 15 years lung transplantation participated four selfreport instruments used assessment basel assessment adherence immunosuppressive medication scale newest vital sign psychological general wellbeing organ transplant symptom wellbeing instrument statistical analysis performed results thirty percent lung recipients nonadherent common nonadherence dimension taking dose 43 punctual regimen 80 working full time part time 43 nonadherent p032 higher level nonadherence reported long time lutx highest level 3year followup conclusion level nonadherence among lung recipients high highest levels found among returned work nonadherence increased time lung transplantation